Sellas Life Sciences
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -6,918 | -7,329 | -7,621 | -9,645 |
EBIT | -15,242 | -19,290 | ||
Net Income | -6,737 | -7,108 | -7,470 | -9,566 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -7,153 | -7,806 | -9,682 | -10,761 |
Cash | 13,886 | 21,031 | 9,247 | 18,515 |
Basic Shares | 612,024 | 614,286 | 518,674 | 403,316 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $1,000 | $7,600 |
Gross Profit | 0 | 900 | 7,400 | |
EBITDA | -31,513 | 529 | -31,950 | -19,663 |
EBIT | -37,340 | -32,407 | -20,936 | |
Net Income | -30,881 | -37,340 | -40,652 | -20,699 |
Net Change In Cash | 0 | 0 | 1,000 | 7,600 |
Free Cash Flow | -35,402 | -36,910 | -28,309 | -26,021 |
Cash | 13,986 | 2,530 | 17,125 | 21,355 |
Basic Shares | 612,024 | 249,993 | 174,561 | 139,330 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.08 |
2024-09-30 | -$0.10 |
2024-06-30 | -$0.13 |
2024-03-31 | -$0.21 |
